BDX

BCAL FPO [BDX]
BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer. It develops BREASTESTplus, a first-in-class blood test designed to be used alongside standard mammogram in breast cancer screening. The company also develops BREASTEST, BCAL Diagnostics, and BCAL Dx. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
Healthcare · ASX Small Cap
$0.0750 -5.1%

Updated 21 Jul 2026 · Signals refresh every scan

Get alerts when BDX triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track BDX — Free

Active Signals

Bullish Signals

  • Bollinger Bands are tightening — volatility is coiling up for a potential breakout
  • Beating the Small Ords index — relative strength of 1.10, so it's outpacing the pack
  • Volatility is contracting — like a spring being compressed, breakouts often follow
  • Low cash runway (2 quarters) - dilution risk
  • Moderate P/S ratio (10.9x)
  • Small-cap ($20-100M)
  • New substantial holder(s) (1)
  • CANSLIM S: Tight float (49%)
  • Sentiment is mixed — no strong consensus either way
  • The bigger volume days are the up days — volume-weighted momentum is positive (30.87%/day)
  • RBA hiking (-3pts)
  • Calendar: Quarterly 4C in 5d (+5pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Revenue declining (-8%)
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Deeply negative margins (-282%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about BDX
"What's driving BDX today?" "How does BDX compare to peers?" "Key risks for BDX?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Notification regarding unquoted securities - BDX
NONE Notification regarding unquoted securities - BDX
NONE Notification regarding unquoted securities - BDX
HIGH Becoming a substantial holder from BDX
Announcement tone +3pts

Recent ASX Announcements

2026-07-14 Notification regarding unquoted securities - BDX
2026-07-14 Notification regarding unquoted securities - BDX
2026-07-14 Notification regarding unquoted securities - BDX
2026-07-14 Notification regarding unquoted securities - BDX
2026-07-02 Becoming a substantial holder from BDX

Key Metrics

$27.7M
Market Cap
159K
Avg Volume
0.8x
Vol Ratio
$0.05 — $0.15
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-121.7%
ROE
-282.1%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 48%
LLeader vs LaggardlaggardRS: -2
IInstitutional SponsorshipweakInst: 3%
MMarket DirectionneutralNeutral

Sector: Healthcare

111 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
ECS +20.0%VHL -15.4%NTI +12.5%PIQ -11.4%OSL -10.3%
Compare:BDX vs ECSBDX vs VHLBDX vs NTI
Scout Pro — Deeper Analysis for BDX
Try Pro free for 30 days
Share this analysis

Track BDX and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required